n(g),n(g')-dimethyl-l-arginine has been researched along with Bronchopulmonary Dysplasia in 3 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that levels of the endogenous inhibitor of nitric oxide production, asymmetric dimethylarginine (ADMA), would be greater in preterm infants with bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) than in infants with BPD alone." | 7.81 | Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension. ( Backes, CH; Chen, B; Klebanoff, MA; Nelin, LD; Peterson, E; Rogers, LK; Trittmann, JK, 2015) |
| "To test the hypothesis that levels of the endogenous inhibitor of nitric oxide production, asymmetric dimethylarginine (ADMA), would be greater in preterm infants with bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) than in infants with BPD alone." | 3.81 | Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension. ( Backes, CH; Chen, B; Klebanoff, MA; Nelin, LD; Peterson, E; Rogers, LK; Trittmann, JK, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trittmann, JK | 1 |
| Peterson, E | 1 |
| Rogers, LK | 1 |
| Chen, B | 1 |
| Backes, CH | 1 |
| Klebanoff, MA | 1 |
| Nelin, LD | 1 |
| Aschner, JL | 1 |
| Fike, CD | 1 |
| Kavurt, S | 1 |
| Demirel, N | 1 |
| Bas, AY | 1 |
| Ulubas Isık, D | 1 |
| Ozcan, B | 1 |
| Aydemir, O | 1 |
3 other studies available for n(g),n(g')-dimethyl-l-arginine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.
Topics: Arginine; Bronchopulmonary Dysplasia; Case-Control Studies; Humans; Hypertension, Pulmonary; Infant, | 2015 |
Plasma asymmetric dimethylarginine in infants with bronchopulmonary dysplasia: a promising biomarker despite uncertain pathogenic significance.
Topics: Arginine; Bronchopulmonary Dysplasia; Humans; Hypertension, Pulmonary | 2015 |
Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Topics: Arginine; Biomarkers; Birth Weight; Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Inf | 2017 |